BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 33468256)

  • 1. Multitasking guardian of mitochondrial quality: Parkin function and Parkinson's disease.
    Kamienieva I; Duszyński J; Szczepanowska J
    Transl Neurodegener; 2021 Jan; 10(1):5. PubMed ID: 33468256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nix restores mitophagy and mitochondrial function to protect against PINK1/Parkin-related Parkinson's disease.
    Koentjoro B; Park JS; Sue CM
    Sci Rep; 2017 Mar; 7():44373. PubMed ID: 28281653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkin and PINK1 functions in oxidative stress and neurodegeneration.
    Barodia SK; Creed RB; Goldberg MS
    Brain Res Bull; 2017 Jul; 133():51-59. PubMed ID: 28017782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's disease-associated VPS35 mutant reduces mitochondrial membrane potential and impairs PINK1/Parkin-mediated mitophagy.
    Ma KY; Fokkens MR; Reggiori F; Mari M; Verbeek DS
    Transl Neurodegener; 2021 Jun; 10(1):19. PubMed ID: 34127073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PINK1, Parkin, and Mitochondrial Quality Control: What can we Learn about Parkinson's Disease Pathobiology?
    Truban D; Hou X; Caulfield TR; Fiesel FC; Springer W
    J Parkinsons Dis; 2017; 7(1):13-29. PubMed ID: 27911343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-degron-mediated degradation and regulation of mitochondrial PINK1 kinase.
    Eldeeb MA; Ragheb MA
    Curr Genet; 2020 Aug; 66(4):693-701. PubMed ID: 32157382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkin, an E3 Ubiquitin Ligase, Plays an Essential Role in Mitochondrial Quality Control in Parkinson's Disease.
    Wang XL; Feng ST; Wang ZZ; Yuan YH; Chen NH; Zhang Y
    Cell Mol Neurobiol; 2021 Oct; 41(7):1395-1411. PubMed ID: 32623547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PINK1/PARKIN signalling in neurodegeneration and neuroinflammation.
    Quinn PMJ; Moreira PI; Ambrósio AF; Alves CH
    Acta Neuropathol Commun; 2020 Nov; 8(1):189. PubMed ID: 33168089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial CISD1/Cisd accumulation blocks mitophagy and genetic or pharmacological inhibition rescues neurodegenerative phenotypes in Pink1/parkin models.
    Martinez A; Sanchez-Martinez A; Pickering JT; Twyning MJ; Terriente-Felix A; Chen PL; Chen CH; Whitworth AJ
    Mol Neurodegener; 2024 Jan; 19(1):12. PubMed ID: 38273330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkin, PINK1 and mitochondrial integrity: emerging concepts of mitochondrial dysfunction in Parkinson's disease.
    Pilsl A; Winklhofer KF
    Acta Neuropathol; 2012 Feb; 123(2):173-88. PubMed ID: 22057787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LRRK2 impairs PINK1/Parkin-dependent mitophagy via its kinase activity: pathologic insights into Parkinson's disease.
    Bonello F; Hassoun SM; Mouton-Liger F; Shin YS; Muscat A; Tesson C; Lesage S; Beart PM; Brice A; Krupp J; Corvol JC; Corti O
    Hum Mol Genet; 2019 May; 28(10):1645-1660. PubMed ID: 30629163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PINK1 and Parkin – mitochondrial interplay between phosphorylation and ubiquitylation in Parkinson's disease.
    Kazlauskaite A; Muqit MM
    FEBS J; 2015 Jan; 282(2):215-23. PubMed ID: 25345844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic approaches to enhance PINK1/Parkin mediated mitophagy for the treatment of Parkinson's disease.
    Miller S; Muqit MMK
    Neurosci Lett; 2019 Jul; 705():7-13. PubMed ID: 30995519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PINK1-Parkin axis: An Overview.
    Tanaka K
    Neurosci Res; 2020 Oct; 159():9-15. PubMed ID: 31982458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Michael J. Fox Foundation for Parkinson's Research Strategy to Advance Therapeutic Development of PINK1 and Parkin.
    Padmanabhan S; Polinski NK; Menalled LB; Baptista MAS; Fiske BK
    Biomolecules; 2019 Jul; 9(8):. PubMed ID: 31344817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PINK1/Parkin-mediated mitophagy is compromised by PD-associated mutations.
    Geisler S; Holmström KM; Treis A; Skujat D; Weber SS; Fiesel FC; Kahle PJ; Springer W
    Autophagy; 2010 Oct; 6(7):871-8. PubMed ID: 20798600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation by mitophagy.
    Hattori N; Saiki S; Imai Y
    Int J Biochem Cell Biol; 2014 Aug; 53():147-50. PubMed ID: 24842103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitophagy: the latest problem for Parkinson's disease.
    Vives-Bauza C; Przedborski S
    Trends Mol Med; 2011 Mar; 17(3):158-65. PubMed ID: 21146459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The endoplasmic reticulum/mitochondria interface: a subcellular platform for the orchestration of the functions of the PINK1-Parkin pathway?
    Erpapazoglou Z; Corti O
    Biochem Soc Trans; 2015 Apr; 43(2):297-301. PubMed ID: 25849933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1.
    Geisler S; Holmström KM; Skujat D; Fiesel FC; Rothfuss OC; Kahle PJ; Springer W
    Nat Cell Biol; 2010 Feb; 12(2):119-31. PubMed ID: 20098416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.